{"nctId":"NCT01585155","briefTitle":"Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis","startDateStruct":{"date":"2012-02"},"conditions":["Pediatric Ulcerative Colitis"],"count":21,"armGroups":[{"label":"TA-650","type":"EXPERIMENTAL","interventionNames":["Drug: TA-650"]}],"interventions":[{"name":"TA-650","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients who have been diagnosed as ulcerative colitis at least 3 months prior to screening.\n* Have active ulcerative colitis despite adequate conventional therapy.\n\nExclusion Criteria:\n\n* Patients who have severe pancolitis.\n* Patients who have undergone surgery for ulcerative colitis within 8 weeks before enrollment or who were judged to require surgery for ulcerative colitis at enrollment.\n* Patients who have a history of treatment with infliximab or other biologic products (anti-TNFÎ± agents, anti-IL-6 agents, etc.).","healthyVolunteers":false,"sex":"ALL","minimumAge":"6 Years","maximumAge":"17 Years","stdAges":["CHILD"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Percent of Patients Who Achieved CAI Remission","description":"Clinical activity index (CAI) remission was defined as a case where a CAI score was not more than 4 on the evaluation day.\n\nCAI score was an activity index to evaluate disease activity, which is calculated as the sum (0 to 29 points) of subscores for 7 clinical conditions, consisting of the number of stools per week, blood in stools (based on weekly average), investigator's global assessment of the symptomatic state, abdominal pain/cramps, temperature elevation due to ulcerative colitis, extraintestinal manifestations, and laboratory findings (hemoglobin or ESR). A higher score indicates greater disease activity.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"60.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"80.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"80.0","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"77.8","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"87.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"87.5","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"64.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"85.7","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"64.3","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"42.9","spread":null}]}]}]},{"type":"SECONDARY","title":"CAI Score","description":"CAI score was an activity index to evaluate disease activity, which is calculated as the sum (0 to 29 points) of subscores for 7 clinical conditions, consisting of the number of stools per week, blood in stools (based on weekly average), investigator's global assessment of the symptomatic state, abdominal pain/cramps, temperature elevation due to ulcerative colitis, extraintestinal manifestations, and laboratory findings (hemoglobin or ESR). A higher score indicates greater disease activity.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.7","spread":"2.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.0","spread":"3.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.5","spread":"3.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.2","spread":"3.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.7","spread":"2.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.7","spread":"3.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.6","spread":"2.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.3","spread":"3.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.5","spread":"2.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.5","spread":"2.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"5.6","spread":"3.8"}]}]}]},{"type":"SECONDARY","title":"Partial Mayo Score","description":"Mayo score consists of four subscores (stool frequency, rectal bleeding, physician's global assessment and findings of endoscopy), each of which was assessed according to a four-level rating scale (0 to 3 points), and was determined from a total of the four subscores (0 to 12 points). In addition, the sum of the subscores (0 to 9 points) for stool frequency, rectal bleeding and physician's global assessment was used as a partial Mayo score. A higher score indicates greater disease activity.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.6","spread":"1.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.6","spread":"2.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.2","spread":"2.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.7","spread":"1.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.2","spread":"2.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.9","spread":"1.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.1","spread":"1.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.4","spread":"2.1"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"1.8","spread":"1.7"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"2.8","spread":"1.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"3.7","spread":"2.2"}]}]}]},{"type":"SECONDARY","title":"Pediatric Ulcerative Colitis Activity Index (PUCAI) Score","description":"PUCAI score was determined as a total of the subscores for each of the six evaluation items (0 to 85), including abdominal pain, rectal bleeding, stool consistency of most stools, number of stools per 24 hours, nocturnal stools and activity level. A higher score indicates greater disease activity.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"47.1","spread":"15.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"20.3","spread":"16.3"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"17.3","spread":"17.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.5","spread":"13.5"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.7","spread":"16.9"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"12.2","spread":"12.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"14.4","spread":"16.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"18.2","spread":"15.6"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"13.2","spread":"14.0"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"19.3","spread":"18.8"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"28.8","spread":"22.5"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":3,"n":21},"commonTop":["Double stranded DNA antibody positive","Nasopharyngitis","Enteritis infectious","Upper respiratory tract infection","Iron deficiency anaemia"]}}}